PIPERIDIN-4-YL-AMIDE DERIVATIVES AND THEIR USE AS SST RECEPTOR SUBTYPE 5 ANTAGONISTS
申请人:F. HOFFMANN-LA ROCHE AG
公开号:EP1893603A1
公开(公告)日:2008-03-05
POLYIMIDE PRECURSOR, POLYIMIDE, AND COATING SOLUTION FOR UNDER LAYER FILM FOR IMAGE FORMATION
申请人:NISSAN CHEMICAL INDUSTRIES, LTD.
公开号:US20140155546A1
公开(公告)日:2014-06-05
There is provided a polyimide precursor which can alter the hydrophilicity/hydrophobicity of the surface of a cured film formed readily even by a low level of ultraviolet ray irradiation; and a polyimide produced from the polyimide precursor. The polyimide precursor having a structure represented by the following formula (1):
where A represents a tetravalent organic group; B represents a bivalent organic group having a thiol ester bond in its main chain; R
1
and R
2
independently represent a hydrogen atom or a univalent organic group; and n represents a natural number.
US7772253B2
申请人:——
公开号:US7772253B2
公开(公告)日:2010-08-10
[EN] PIPERIDIN-4-YL-AMIDE DERIVATIVES AND THEIR USE AS SST RECEPTOR SUBTYPE 5 ANTAGONISTS<br/>[FR] DERIVES DE LA PIPERIDIN-4-YL-AMIDE ET LEUR UTILISATION COMME ANTAGONISTES DU SOUS TYPE 5 DU RECEPTEUR SST
申请人:HOFFMANN LA ROCHE
公开号:WO2006128803A1
公开(公告)日:2006-12-07
[EN] This invention is concerned with compounds of the formula (1) wherein R1 to R5, R5' and A are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5. [FR] Cette invention concerne les composés de formule (1) dans laquelle R1 à R5, R5' et A sont tels que définis dans la description et les revendications, et leurs sels acceptables sur un plan pharmaceutique. L'invention concerne de plus des compositions pharmaceutiques contenant de tels composés, un procédé pour leur préparation et leur utilisation pour le traitement et/ou la prévention de maladies qui sont associées à la modulation du sous type 5 des récepteurs SST.